Home›Stock Screener›Venus Remedies›P/E Ratio

Venus Remedies P/E Ratio

Current P/E Ratio
20.53
Moderate Valuation
High - Growth expectations or overvalued

Venus Remedies P/E ratio. Venus Remedies (VENUSREM) P/E ratio is 20.53 (Moderate), EPS (TTM) ₹76.90, current price ₹1796.10 on NSE vs historical average P/E of 12.28 (100.0th percentile) — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see Venus Remedies screener.

Current Valuation Metrics

P/E Ratio 20.53
Current Price ₹1796.10
EPS (TTM) ₹76.90
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 12.28
Historical Range 6.96 - 18.69
Percentile 100.0%

Sector Context

Sector Average 56.37
Sector Median 32.5
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹83.48
Mar 2026 ₹35.53
Jun 2026 ₹17.18

VENUSREM P/E Ratio — Valuation Signal & Historical Context

Venus Remedies P/E 20.53 vs historical average 12.28, range 6.96–18.69 — signal: Overvalued. Also explore VENUSREM share price data to track price trends across different timeframes.

  • Current PE is 67.1% above historical average
  • Trading at discount to sector average PE of 56.37

Venus Remedies P/E Ratio Historical Trend

VENUSREM annual price-to-earnings ratio — 5 years, EPS and year-end price. Current P/E 20.53 vs historical average 12.28. Examine Venus Remedies quarterly financials for recent quarterly revenue, profit and EPS trends.

VENUSREM Historical P/E Ratio — EPS, Year-End Price & Valuation

Venus Remedies annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 8.11 57.09 ₹462.75 NSE Low
2024 12.28 26.07 ₹320.15 BSE Low
2023 18.69 21.72 ₹405.95 BSE Moderate
2022 15.38 11.78 ₹181.15 BSE Moderate
2021 6.96 58.85 ₹409.60 BSE Low

VENUSREM vs Healthcare Peers — P/E Ratio Comparison

Venus Remedies P/E 20.53 vs Healthcare average 56.37, median 32.5 — range 2.04–740.29.

Sector Average
56.37
Sector Median
32.5
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 3.98 ₹6,206 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
GKB Ophthalmics GKB 5.88 ₹32 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low